Success Story: EB1A Approved Despite RFE! Dual NIW + EB1A Victory for Indian Medical Director via Premium Processing
Client’s Testimonial:
“It has been a pleasure working with Chen on my EB1A NIW journey. I heard about Chen years ago and hence had the confidence to go with them. I liked their meticulous attitude in preparing the case draft and collecting evidence. Chen has a ton of experience with EB1 and NIW categories. Chen has also been prompt in responding to my queries. I was told the officer who had issued my RFE had only a 30% approval rate. I was nervous due to the recent significant drop in the EB1A approval rate. However, Chen was a great help throughout the process, and I am satisfied with her service. I wish them all the best and endorse her for physicians willing to file an EB1A NIW petition.”
On February 27th, 2025, and June 21st, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Medical Director of Post Acute Network in the Field of Internal Medicine (Approval Notice).
General Field: Internal Medicine
Position at the Time of Case Filing: Medical Director of Post Acute Network
Country of Origin: India
State of Residence at the Time of Filing: Illinois
Approval Notice Date: : February 27th, 2025 (NIW) and June 21st, 2025 (EB1A)
Processing Time: 1 month, 28 days (NIW), and 3 months, 15 days (EB1A) (Premium Processing Requested)
Case Summary:
We are proud to share the dual approval of the National Interest Waiver (NIW) and EB1A I-140 petitions for a highly accomplished physician-scientist from India. Her NIW petition was approved in February 2025, and her EB1A, filed under premium processing, was approved in June 2025 after a successful response to a Request for Evidence (RFE). These outcomes reflect both the national significance and extraordinary caliber of her contributions to internal medicine, geriatrics, artificial intelligence, and gastroenterology.
Advancing Clinical Innovation Through AI and Personalized Healthcare
The petitioner holds an M.B.B.S. degree from India and an MD degree from the USA and is currently employed in a medical director role in the United States. Her research integrates internal medicine with AI-driven digital health solutions. She is best known for developing a novel digital phenotyping platform and smartphone app that delivers real-time, personalized mental health support – an approach that has gained wide adoption for its transformative potential in modern healthcare delivery.
Her contributions also span areas such as hepatocellular carcinoma diagnostics and postoperative delirium prevention in older adults, critical domains of national concern due to their high prevalence and associated costs.
Objective Impact and Global Recognition
At the time of filing, she had authored 23 peer-reviewed journal articles, 7 conference abstracts, 1 book chapter, and 1 book. Her work has been cited 641 times, with three articles ranked among the top 1–10% most cited in Clinical Medicine for their publication years. She has also completed 9 verified peer reviews for academic journals and conferences.
Her publications appear in highly ranked journals, underscoring the quality and influence of her work.
Expert Endorsements from the Scientific Community
The petition included six letters of recommendation from respected scholars in medicine and public health, five of whom were independent. These experts confirmed the originality and wide-reaching impact of her research.
“Her contributions are of great value to the U.S. healthcare system, and I have no doubt that she will continue to drive meaningful advancements in medicine.”
A Strong Case, A Well-Earned Success
By demonstrating both sustained national impact and extraordinary ability, the petitioner earned swift approvals in both the NIW and EB1A categories. We are honored to support her continued mission to improve healthcare outcomes through cutting-edge medical research and digital innovation.